Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,967 total articles
Actuate Therapeutics announced FDA clearance for an IND to begin Phase 1/2 clinical trials of their oral elraglusib formulation in advanced cancers including metastatic melanoma, NSCLC, colorectal, and pancreatic cancers, aiming to improve patient convenience and drug exposure. The company also revealed plans to study elraglusib in combination with…
Hain Celestial announced its fiscal third quarter 2026 financial results, reporting a 13% year-over-year decline in net sales to $338 million, with organic net sales down 6%. Despite lower revenues and a net loss of $106 million driven partly by asset impairments and the sale of its North American snacks business, the company improved its financial…
Fractyl Health received authorization to start a Phase 1/2 clinical trial of RJVA-001, its first gene therapy candidate aimed at treating type 2 diabetes by enabling nutrient-responsive GLP-1 expression in the pancreas. This marks the company's advancement to a dual clinical-stage biotech, with RJVA-001 being the first adeno-associated virus-based …
SailPoint, a leader in enterprise identity security, announced the launch of SailPoint Agentic Fabric, a solution designed to govern and secure AI agents and non-human identities at scale. This new platform extends identity security beyond human users to AI agents, machines, and applications, providing unified discovery, governance, and protection …
Multi Ways Holdings Limited, a NYSE American-listed heavy construction equipment supplier in Singapore and the surrounding region, announced a 44.2% revenue increase to $44.8 million for fiscal year 2025. The company's equipment sales grew 54%, driven by robust infrastructure projects and public-private construction activities in Singapore. Improve…
Village Farms International, Inc. reported a robust first quarter for 2026, highlighting a 27% increase in consolidated net sales to $50.2 million and a 118% surge in adjusted EBITDA from continuing operations to $9.9 million. Key growth drivers include a 171% increase in international medical cannabis exports and continued market share gains in Ca…
Alpha Tau Medical Ltd. announced groundbreaking interim results from their U.S. trial of Alpha DaRT therapy in patients with recurrent glioblastoma. Among the first three patients treated, two showed complete responses with total tumor disappearance, while the third had stable disease and tumor reduction. The treatment was generally well tolerated …
Gain Therapeutics announced its Q1 2026 financial results along with significant progress in clinical development of its lead Parkinson's disease drug candidate GT-02287. The company highlighted promising Phase 1b study data indicating potential disease-modifying effects, ongoing FDA engagement, and plans to initiate Phase 2 clinical trials in Q3 2…
Lexeo Therapeutics reported Q1 2026 financial results and operational highlights, including FDA submission of SUNRISE-FA 2 pivotal trial protocol for LX2006, presentation of new data at ASGCT 2026, and a strong cash position of $227.6 million to fund operations into 2028. The company made progress in clinical trials for genetic cardiovascular disea…
MBX Biosciences provided preliminary blinded Phase 1 data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity, demonstrating mean weight loss of 7% at 8 weeks and a pharmacokinetic profile supportive of once-monthly dosing. The drug was generally well tolerated with minimal gastrointestinal side effects. The company also announced MBX 5765 as …
Erasca, Inc. announced a clinical collaboration and supply agreement with Merck to conduct the AURORAS-1 study evaluating their investigational pan-RAS molecular glue ERAS-0015 in combination with Merck's KEYTRUDA (pembrolizumab) for RAS-mutant solid tumors. The agreement includes Merck supplying pembrolizumab at no cost and aims to improve treatme…
Rezolute, Inc., a late-stage biotechnology company focused on rare diseases related to hyperinsulinism, announced its management will participate in two major upcoming investor conferences. The participation includes fireside chats and one-on-one meetings, aiming to update investors on their developments, including their antibody therapy ersodetug,…
Keel Infrastructure Corp., rebranded and redomiciled in the U.S., reported its Q1 2026 financial results highlighting a strategic shift from Bitcoin mining to high-performance computing (HPC) and AI data center infrastructure in North America. The company reported a net loss of $145 million primarily due to operational costs, impairments, and adjus…
ARKO Petroleum Corp. announced robust financial results for Q1 2026, including a net income increase to $8.1 million and adjusted EBITDA up to $36.4 million compared to the previous year. The company completed an IPO raising $206.7 million used to significantly reduce debt, enhancing financial flexibility. Growth strategies include converting retai…
Kaspi.kz announced robust financial results for Q1 2026 with a 41% year-over-year growth in e-Commerce gross merchandise value and a 9% increase in adjusted EBITDA. The company highlighted increased consumer purchase frequency and improved monetization, particularly in advertising and delivery services. Kaspi.kz is expanding internationally with si…
Olaplex Holdings, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting a 2.5% increase in net sales to $99.4 million but a net loss of $5.3 million compared to net income in the prior year period. The company highlighted positive sales trends driven by the launch of No. 3 PLUS and progress in its transformation…
Elme Communities provided an update on its ongoing liquidation process, having sold five properties in 2026 and entering agreements for four more, targeting completion of all sales by mid-2026. The company adjusted its estimated total liquidating distributions to $16.74-$17.02 per share, down from prior estimates, due to softer market conditions an…
Nova Minerals Limited successfully completed its 2026 winter freight mobilization to its Estelle Project in Alaska, delivering essential heavy equipment and supplies for mining and processing antimony ore. The company is now poised to begin construction of new infrastructure including access trails, an airstrip expansion, and an ore sorting and pro…
Apollo-managed funds have agreed to acquire Emerald Holding, Inc. and Questex, LLC in all-cash transactions to combine the two companies into a leading North American B2B experiential events and media platform. Emerald shareholders will receive a 42.1% premium per share, with the transaction valued at approximately $1.5 billion. The merger aims to …
Liquidia Corporation reported first quarter 2026 financial results highlighting approximately $130 million in net product sales of YUTREPIA®, sustained patient uptake, and net income of $53 million—marking its third consecutive profitable quarter. The company continues to advance clinical programs for its pulmonary hypertension treatments and expan…
Certara, Inc. reported its Q1 2026 financial results with 1% revenue growth to $106.9 million driven by 7% growth in software revenue, while services revenue declined 4%. The company posted a net loss of $8.8 million compared to net income of $4.7 million a year ago, primarily due to higher operating expenses related to acquisitions, employee costs…
Zhihu Inc., a leading Chinese online content community, has announced it will release its unaudited financial results for the first quarter ended March 31, 2026 on June 3, 2026, before U.S. market open. The company's management will host a conference call to discuss the results. Zhihu is listed on both the NYSE and HKEX.
Click Holdings Limited (NASDAQ: CLIK), a Hong Kong-based leader in AI-powered human resources and senior care solutions, announced strong interim financial results for the six months ended December 31, 2025. The company reported a 57.3% increase in total revenue to HK$59 million and swung from a loss to a profit, driven mainly by a 117.8% surge in …
At its 2026 Annual General Meeting, VEON Ltd. shareholders re-elected all seven current Board members including founder and Chairman Augie K Fabela II, signaling strong shareholder confidence in the company's digital growth strategy. The company reported robust financial results for FY25, with a 9.9% revenue increase and a 62.5% surge in direct dig…
Barrick Mining Corporation delivered a strong first quarter in 2026, with gold production reaching 719,000 ounces, beating guidance estimates. The company reported net earnings per share of $0.96, a 256% increase year-over-year, driven by higher realized gold prices and operational efficiencies. Operating cash flow more than doubled compared to las…
